Effects of Continuous Mobility Training in Prolonged Mechanical Ventilation (NCT05688267) | Clinical Trial Compass
CompletedNot Applicable
Effects of Continuous Mobility Training in Prolonged Mechanical Ventilation
Taiwan56 participantsStarted 2023-02-01
Plain-language summary
Background: The exercise intervention can help participants with prolonged mechanical ventilation improve ventilator weaning; however, the content of exercise intervention is diverse and inconsistent.
Objective: This study aims to design the continuous mobility training and examine the clinical effects in participants with prolonged mechanical ventilation.
Methods: This prospective, single-center, concealed allocation, evaluator-blind, randomized control study divided participants transferred from the intensive care unit to the respiratory care center into two groups. The control group underwent the routine ventilator weaning plan and hand bicycle training, while the experimental group underwent routine ventilator weaning plan and continuous mobility training plan. The success rate of ventilator weaning, length of mechanical ventilation, length of stay at the respiratory care center, and total length of hospital stay were analyzed.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Aged over 18 years, regardless of sex.
. Use of mechanical ventilation and transfer from the intensive care unit to the respiratory care center for weaning.
. Stable vital signs.
. Ability to understand simple instructions and agree to participate in this research program after explanation.
Exclusion criteria
. Unconsciousness, severe cognitive impairment, or inability to follow instructions.
. Severe heart failure (NYHA ≥ 3).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
. Diagnosis of terminal illness and undergoing palliative care.
. Inability to receive exercise therapy due to physical conditions, fracture, lower limb surgery, acute thrombosis, open wounds, extracorporeal membrane oxygenation.
. Assessment by other attending physician that the participant's condition, progression of disease course or treatment plan were not suitable for exercise therapy.